With almost 70% of the Brazilian population immunized with at least the first dose of Covid-19 vaccine and the campaign for teenagers already in progress, the doubts about when the little ones under the age of twelve will be able to get vaccinated come to light. Even more so with the increase of countries that are including children in their lists of immunized.
After Chile, China and Cuba, the latest nation to immunize children under 12 is Argentina. On Sunday (3), the government announced that it would start vaccinating children from the age of three with Sinopharm.
In Brazil, in August, the National Health Surveillance Agency (ANVISA) denied a request for the application of Coronavac in the group aged between three and 17 years, due to the need to prove the safety and efficacy of the biopharmaceutical vaccine Sinovac.
Since then advances in research promoted by manufacturers have been announced and the release of immunization for this range is closer to becoming a reality for all countries. But for now, it still isn’t.
How is the vaccination campaign going around the world?
Like Brazil, countries like the United States, Canada, France, Denmark, Norway and Germany are vaccinating their population of young people over 12, but not yet including the youngest. See, below, who has already approved the use of immunizers for other age groups:
Cuba: The country was one of the first to start the campaign on children. National vaccines, Sovereign and Abdallah, started to be applied in the population with more than two years in early September, taking into account the need to go back to school and the increase in Delta variant cases.
China: Nevertheless, the China had already approved the use of CoronaVac, an immunizing agent developed by Chinese pharmaceutical Sinovac, for the age group of three to seventeen years since June this year.
Chile: The country was a pioneer in the vaccination campaign for children from six years. A CoronaVac was the immunizing agent approved for use in the beginning of the third week of September, starting with the groups with comorbidities.
The Savior: Also in September, the President of El Salvador, Nayib Bukele, announced that the country would also adhere to vaccination for children between six and twelve years. With no specific dates for the start of the campaign, the country gathers immunization agents from pharmaceutical companies Pfizer, Modern, Sinovac e Oxford.
UAE: The immunization of children between three and eleven years in the country, but it is not yet mandatory. For now, the only vaccine released for this group is the Sinopharm, developed in China.
Argentina: Finally, the country announced on the first Sunday of October that it will also start vaccinating children between three and eleven years. The Chinese Vaccine Sinopharm is the immunizing agent available to the group and the country intends to end the year with the age group protected against Covid.
And the Pfizer release?
In conjunction with BioNTech, Pfizer announced on Tuesday, the 28th, that the positive results of immunization tests in children aged 5 to 11 years old were forwarded to the Food and Drug Administration (FDA) of the United States.
Phase 2 data included more than 2,200 participants and demonstrated safety in the response to the application of the immunizer in the group. “The results of these tests provide a solid basis for obtaining authorization for our vaccine for children aged 5 to 11 years,” the company says in a statement.
Along with the disclosure of this information, Pfizer also announced that it would soon forward to the US agency a request for an authorization to emergency use of the vaccine in the coming weeks and would disclose the data obtained with the European Medicines Agency (EMA). The next steps also include submitting the results to Anvisa so that vaccination can take place in Brazil.
Although other pharmaceutical companies are also in testing phases with the immunization of this age group, the results presented by Pfizer may be more favorable and promising for approval of use in our country.